The General Hospital Corporation;University of Iowa Research Foundation
发明人:
申请号:
EP14863892.7
公开号:
EP3071240A4
申请日:
2014.11.20
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present disclosure provides methods of determining A-beta in a mammal before and after treatment of an amyloid disorder, comprising obtaining a first blood sample from the mammal; administering to the mammal a treatment for an amyloid disorder; obtaining a second blood sample from the mammal; quantifying a level of A-beta in the first blood sample and in the second blood sample; and determining the level of A-beta in the mammal before and after treatment of the amyloid disorder.